€34.75
2.21% yesterday
Xetra, Nov 15, 05:38 pm CET
ISIN
DE000A2GS5D8
Symbol
DMP
Index
Sector
Industry

Dermapharm Dividend history 6 years & estimates 2024 to 2026

Powered by StocksGuide
Register now for free to see the dividend history & estimates. Unlock now

Dividend Analysis of the Dermapharm Stock

Current dividend yield 3.82 %
Dividendenrendite 5 Jahre 3.94 %
Dividend Yield 10Y 6.47 %
Payout 3Y 6.02 %

When does Dermapharm pay a dividend?

Year Dividend Ex-day &
Payday
Frequency
Fiscal Year Dividend per Share Ex-Day Payday Payment frequency
2023
€0.88
€0.88
Jun 28 2024
Jun 28 2024
Jul 02 2024
Jun 28 24
Jul 02 24
Jul 02 2024
-
-
2022
€1.05
€1.05
Jun 15 2023
Jun 15 2023
Jun 19 2023
Jun 15 23
Jun 19 23
Jun 19 2023
-
-
2021
€2.17
€2.17
Jun 02 2022
Jun 02 2022
Jun 06 2022
Jun 02 22
Jun 06 22
Jun 06 2022
-
-
2020
€0.88
€0.88
Jun 24 2021
Jun 24 2021
Jun 28 2021
Jun 24 21
Jun 28 21
Jun 28 2021
annual
yearly
2019
€0.8
€0.8
Jun 18 2020
Jun 18 2020
Jun 22 2020
Jun 18 20
Jun 22 20
Jun 22 2020
-
-
2018
€0.77
€0.77
Jun 05 2019
Jun 05 2019
Jun 07 2019
Jun 05 19
Jun 07 19
Jun 07 2019
annual
yearly

How much dividend does Dermapharm pay?

Dermapharm most recently paid a dividend of €0.88. Dermapharm paid a Dividend of €0.88 Per Share in the financial year 2023. With a stock price of €34.00 at Nov 14 2024, the current dividend yield is 2.59% (calculation: €0.88 / €34.00 = 2.59%). No special dividend was paid.

Use the StocksGuide screener to find the stocks with the highest dividend yields. Here you will find, for example, the 100 largest dividend stocks in the world:

What is the Dermapharm Dividend Yield and payout ratio?

The average Dermapharm dividend yield over the last 5 years is 2.40% and the average over the last 10 years is 1.46%.

The payout ratio of Dermapharm in relation to the last financial year is 75.86%. The payout ratio smoothed over 3 years is 54.38%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).

Metric Dermapharm
Current dividend yield 2.59%
Dividend Yield 5Y 2.40%
Dividend Yield 10Y 1.46%
Payout 1Y 75.86%
Payout 3Y 54.38%

Is the Dermapharm dividend safe? Continuity & Dividend Growth

Is the Dermapharm dividend safe?

Dermapharm has been paying a dividend for 6 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.

The Dividend Growth in relation to the previous financial year amounts to -16.19%. The average Dermapharm Dividend Growth over the last 5 years is 2.71%.

Metric Dermapharm
Increased 0 Years
Continuity 0 Years
Paid 6 Years
Growth 1Y -16.19%
Growth 5Y 2.71%

Continuity

Dermapharm has been paying a dividend for 6 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.

Dividend Growth

The Dividend Growth in relation to the previous financial year amounts to -16.19%. The average Dermapharm Dividend Growth over the last 5 years is 2.71%.

With the Stock Screener, you can search for the best Dividend Aristocrats in indices such as the DAX or NASDAQ.

Dermapharm Stock Forecast 2024

On the stock exchange, the Dermapharm stock (ISIN: DE000A2GS5D8) is not traded as a top scorer in November 2024 according to the dividend strategy.

The stock price of Dermapharm -17.93% has fallen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the Dermapharm stock price in real time at the top of the page.

Dermapharm (symbol: DMP) is valued at a Price / Earnings Ratio (P/E ratio) of 22.04 and a price/sales ratio (P/S ratio) of 1.62 valued. Based on analyst estimates, the Dermapharm stock forecast 2024 of the current financial year corresponds to a valuation of 17.68 according to P/E ratio and 1.55 according to P/S.

Metric Dermapharm
Dividend Score ??/15
Performance 2024
17.93%
P/E TTM 22.04
P/S TTM 1.62
P/E forward 17.68
P/S forward 1.55

Dermapharm (symbol: DMP) is valued at a Price / Earnings Ratio (P/E ratio) of 22.04 and a price/sales ratio (P/S ratio) of 1.62 valued. Based on analyst estimates, the Dermapharm stock forecast 2024 of the current financial year corresponds to a valuation of 17.68 according to P/E ratio and 1.55 according to P/S.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today